Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.340
-0.010 (-0.74%)
At close: Jun 3, 2025, 4:00 PM
1.320
-0.020 (-1.49%)
After-hours: Jun 3, 2025, 7:09 PM EDT

Chemomab Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$8.50
Upside
+534.33%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$11$10
Buy Maintains $11$10 +646.27% May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$4$7
Strong Buy Maintains $4$7 +422.39% Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$13$11
Buy Reiterates $13$11 +720.90% Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$4
Strong Buy Initiates $4 +198.51% May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$6
Buy Upgrades $6 +347.76% May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$7
Strong Buy Initiates $7 +422.39% Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$7
Strong Buy Initiates $7 +422.39% Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$12$7
Buy Maintains $12$7 +422.39% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$30$20
Buy Maintains $30$20 +1,392.54% Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +2,138.81% Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$45
Buy Initiates $45 +3,258.21% May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$42
Buy Initiates $42 +3,034.33% May 7, 2021